Evidence map›Paper›PMID 10022889›Full record

ArticleMolecular and cellular biology1999

Jun kinase phosphorylates and regulates the DNA binding activity of an octamer binding protein, T-cell factor beta1.

S Kasibhatla, P Tailor, N Bonefoy-Berard, T Mustelin, A Altman, A Fotedar

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.Microbiology and molecular biology reviews : MMBR · 2006
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

S KasibhatlaDivisions of Molecular Biology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121, USA.
P Tailor
N Bonefoy-Berard
T Mustelin
A Altman
A Fotedar
La Jolla Institute for Immunology · USInstitute of Molecular Biology of the Slovak Academy of Sciences · SKSidney Kimmel Cancer Center · US

Funding

T CELLS AND THEIR LYMPHOKINES IN CANCER IMMUNOTHERAPYR01CA035299 · NCI · SCRIPPS RESEARCH INSTITUTE · PI ALTMAN, AMNON · 1985 to 2013
$3.8M
CELL CYCLE REGULATORS AND CELL DEATHR01CA074435 · NCI · SIDNEY KIMMEL CANCER CENTER · PI FOTEDAR, ARUN · 1997 to 2001
$675k
NCI NIH HHS CA35299NCI NIH HHS CA74435NCI NIH HHS R01 CA035299NIAID NIH HHS AI54301
6 · The paper itself

Abstract

POU domain proteins have been implicated as key regulators during development and lymphocyte activation. The POU domain protein T-cell factor beta1 (TCFbeta1), which binds octamer and octamer-related sequences, is a potent transactivator. In this study, we showed that TCFbeta1 is phosphorylated following activation via the T-cell receptor or by stress-induced signals. Phosphorylation of TCFbeta1 occurred predominantly at serine and threonine residues. Signals which upregulate Jun kinase (JNK)/stress-activated protein kinase activity also lead to association of JNK with TCFbeta1. JNK associates with the activation domain of TCFbeta1 and phosphorylates its DNA binding domain. The phosphorylation of recombinant TCFbeta1 by recombinant JNK enhances the ability of TCFbeta1 to bind to a consensus octamer motif. Consistent with this conclusion, TCFbeta1 upregulates reporter gene transcription in an activation- and JNK-dependent manner. In addition, inhibition of JNK activity by catalytically inactive MEKK (in which methionine was substituted for the lysine at position 432) also inhibits the ability of TCFbeta1 to drive inducible transcription from the interleukin-2 promoter. These results suggest that stress-induced signals and T-cell activation induce JNK, which then acts on multiple cis sequences by modulating distinct transactivators like c-Jun and TCFbeta1. This demonstrates a coupling between the JNK activation pathway and POU domain proteins and implicates TCFbeta1 as a physiological target in the JNK signal transduction pathway leading to coordinated biological responses.

Indexed as

Mitogen-Activated Protein KinasesAmino Acid SequenceBinding SitesCalcium-Calmodulin-Dependent Protein KinasesDNADNA-Binding ProteinsHumansInterleukin-2JNK Mitogen-Activated Protein KinasesJurkat CellsMitogen-Activated Protein Kinase 9Molecular Sequence DataPhosphorylationPOU Domain FactorsPromoter Regions, GeneticProtein KinasesCalcium-Calmodulin-Dependent Protein KinasesDNADNA-Binding ProteinsInterleukin-2JNK Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinase 9Mitogen-Activated Protein KinasesPOU6F1 protein, humanPOU Domain FactorsProtein KinasesRecombinant Fusion Proteins

Identifiers

PMID10022889
PMCPMC83995
OpenAlexW2156771171

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.